News
8th April 2026
How gut bacteria could inspire novel colon cancer therapy through glycochemistry
Scientists have drawn inspiration from gut bacteria to suggest a novel way of limiting colon cancer progression
View
20th March 2026
Professor Lindsay Hall elected Fellow of the European Academy of Microbiology
Professor Lindsay Hall has been elected as a new fellow of the European Academy of Microbiology (EAM), which recognises scientific excellence and long-standing contributions to microbiology
View
13th March 2026
Quadram Institute appoints Dr Matthew Gilmour as Chief Scientific Officer
The CSO role is pivotal to the development of the institute’s scientific strategy and the scientific leadership of the institute. Matthew will now take up the role of CSO and will also continue to lead his research group, focused on understanding foodborne pathogens such...
View
12th March 2026
Island birds reveal surprising link between immunity and gut bacteria
Scientists have uncovered a hidden link between gut health and the immune system – thanks to the Seychelles warbler, a small songbird found on Cousin Island in the Seychelles
View
12th March 2026
Salad packs a healthy punch to meet a growing Vitamin B12 need
The partnership between the John Innes Centre and the Quadram Institute, based at the Norwich Research Park, the University of Bristol, and indoor farm specialists LettUs Grow, harnessed the latest aeroponic techniques to successfully deliver the recommended daily allowance (RDA) of Vitamin B12 within...
View
18th February 2026
Understanding the microbiome in severe malnutrition
Children undergoing treatment for severe acute malnutrition lack an effective gut microbiome, which impairs their ability to use dietary fibre, hindering their recovery, according to a new study led by the Quadram Institute. By studying the microbiomes of children hospitalised with severe acute malnutrition,...
View
16th February 2026
Clinical innovation fund backs new research projects to benefit Norfolk patients
The Quadram Institute Clinical Seedcorn Fund was first established in 2021/2022 to help clinicians develop research ideas with scientists at the Quadram Institute. The fund supports secondments of NHS staff to Quadram Institute laboratories and associated research costs. Quadram Institute Bioscience (QIB) in partnership...
View
5th February 2026
Quadram Institute spinoff Quadlytics shortlisted for innovation award
Quadlytics, led by Dr Hannah Morelli, is developing technology that identifies combinations of bacteriophages, commonly called phages, which are helpful viruses that can be used as alternatives to antibiotics to kill bacteria in humans, animals and in the environment as well as contributing to...
View
19th January 2026
Oral bacteria play a role in chronic liver disease
Dr Naiara Beraza contributed to a new study led by the Technical University of Munich (TUM) and King’s College London that has found strong evidence that bacteria from the mouth migrate to the gut in chronic liver disease and exacerbate the disease. Each year,...
View
16th January 2026
Collapse of viral diversity in the lungs of COPD patients
This establishes bacteriophages, which are viruses that infect bacteria, as an unrecognised but potentially important component of the condition, according to a new study from the Quadram Institute, Becky Mayer Centre for Phage Research and Guangzhou Institute of Respiratory Health. Chronic obstructive pulmonary disease...
View

